InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: jmh0602 post# 3191

Thursday, 09/14/2017 11:23:03 AM

Thursday, September 14, 2017 11:23:03 AM

Post# of 3833
Company is maintaining the Dec 2017 deadline as of this week - see R&R deck. So we have clear binary event - it works or not.
If not significant downside

"Phase 2b clinical trial with potential registration endpoints fully enrolled with top line data readout in December 2017"

Slide 25 of the deck

http://galectintherapeutics.com/wp-content/uploads/2017/09/Galectin-Presentation-Updated_9.13.17.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News